RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,414 | +8.1% | 2,913 | +21.6% | 0.00% | 0.0% |
| Q2 2023 | $44,787 | +1.9% | 2,395 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $43,948 | -20.9% | 2,395 | +21.9% | 0.00% | 0.0% |
| Q4 2022 | $55,542 | +18.2% | 1,964 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $47,000 | +56.7% | 1,964 | +18.0% | 0.00% | +100.0% |
| Q2 2022 | $30,000 | -18.9% | 1,664 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $37,000 | -39.3% | 1,664 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $61,000 | +17.3% | 1,664 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $52,000 | +15.6% | 1,664 | +18.1% | 0.00% | 0.0% |
| Q2 2021 | $45,000 | +104.5% | 1,409 | +45.4% | 0.00% | +100.0% |
| Q1 2021 | $22,000 | +15.8% | 969 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $19,000 | -38.7% | 969 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $31,000 | +10.7% | 969 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $28,000 | +833.3% | 969 | +617.8% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 135 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |